Association Between Hemoglobin-Creatinine Ratio and Six-Month All-Cause Readmission in Chinese Patients with Heart

Minghang Li1, Xuyang Li1, Zhang Ye2

  • 1The Second College of Clinical Medicine, Chongqing Medical University, Chongqing, China.

Insights

The hemoglobin-creatinine ratio (HBCR) can predict heart failure (HF) readmissions. Lower HBCR levels are linked to a higher risk of HF readmission within six months, suggesting its utility in patient risk stratification.

Area of Science:

  • Cardiology
  • Nephrology
  • Internal Medicine

Background:

  • Heart failure (HF) readmission is a significant global healthcare challenge.
  • Anemia (hemoglobin [Hb]) and renal dysfunction (creatinine [Cr]) are known HF risk factors.
  • The combined hemoglobin-creatinine ratio (HBCR) as a predictor for HF readmission needs further investigation.

Purpose of the Study:

  • To investigate the association between admission HBCR and six-month all-cause readmission in HF patients.
  • To determine if HBCR can identify high-risk HF patients for targeted interventions.

Main Methods:

  • Retrospective cohort study of 1,833 adult HF survivors.
  • HBCR calculated using admission Hb (g/L) and Cr (µmol/L).
  • Multivariable analysis adjusted for demographics, comorbidities, and laboratory values.

Main Results:

  • 37.6% of patients were readmitted within six months.
  • Lower admission HBCR correlated with increased readmission hazard.
  • Each SD increase in HBCR independently reduced readmission risk by 20% (aHR=0.80).
  • The highest HBCR tertile showed a 41% reduced readmission risk compared to the lowest (aHR=0.59).

Conclusions:

  • Admission HBCR is an independent predictor of six-month all-cause readmission in hospitalized HF patients.
  • HBCR may aid in identifying high-risk patients prior to discharge.
  • Further prospective studies are needed to confirm if HBCR-guided management impacts HF readmission rates.
Abstract

Related Concept Videos

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance (Clcr), a...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...